Compression Therapy Market Size, Chronic Wound Care Demand and Growth Forecast 2026–2034

Compression Therapy Market Overview Analysis By Fortune Business Insights

Market Summary

According to Fortune Business Insights: The global compression therapy market is on a strong upward trajectory. Valued at USD 4.58 billion in 2025, the market is forecast to climb from USD 4.89 billion in 2026 to USD 8.15 billion by 2034, reflecting a compound annual growth rate (CAGR) of 6.60% over the forecast period. This sustained growth is underpinned by the rising global burden of venous and lymphatic disorders, an aging population, and continuous product innovation.

Compression therapy works by applying controlled pressure to the lower extremities to enhance blood circulation and improve the efficiency of the venous and lymphatic systems. It is widely regarded as the most established and clinically important treatment approach for conditions such as lymphedema, venous leg ulcers, and deep vein thrombosis (DVT).

Get a Sample Research PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/102689

Key Market Drivers

Rising Prevalence of Venous and Lymphatic Disorders The growing incidence of conditions like lymphedema, chronic venous insufficiency, and venous leg ulcers is a primary growth engine. Contributing risk factors include obesity, immobility, pregnancy, varicose veins, previous DVT episodes, and breast cancer surgeries. Venous leg ulceration alone is estimated to affect around 1.5% of the general population and up to 5% of the elderly worldwide. Additionally, lymphedema is considered a global health challenge affecting approximately 250 million people, according to the National Center for Biotechnology Information (NCBI).

Product Innovation and New Launches Technological advancements are reshaping the competitive landscape. Conventional single-component bandage systems are being replaced by multi-component and bi-layer systems that deliver superior and more precisely calibrated interface pressure. Companies are also investing in next-generation pneumatic compression devices. Notable milestones include the FDA clearance for AIROS Medical's updated sequential compression therapy devices and Koya Medical's compression system for lower extremities, reflecting an active pipeline of regulatory approvals.

Market Restraints

Despite favorable growth prospects, two key barriers temper the market's expansion. First, high costs associated with compression pumps limit accessibility, particularly in lower-income settings. Second, limited awareness in developing countries about compression therapy as an effective treatment option for venous and lymphatic diseases remains a significant challenge. However, increasing competition is exerting pricing pressure, and leading players are ramping up awareness campaigns to address these gaps.

Segmentation Highlights

By Product Compression garments dominate the market, accounting for an estimated 71.8% share in 2025, driven by widespread clinical adoption for managing venous disorders and a growing geriatric patient base. Sub-categories include compression bandages, stockings, and other wearable solutions. Compression pumps, while a smaller segment, are expected to record the highest growth rate, fueled by increasing product launches and rising recognition of their effectiveness in lymphedema management.

By Application The lymphedema segment holds the leading position in the application landscape, driven by its high global prevalence and growing adoption of compression pumps as a front-line treatment. Venous leg ulcers represent another significant application area, with new compression devices accelerating healing times and reducing recurrence rates. Other key application areas include DVT prevention and management.

By End User Hospitals and clinics lead end-user adoption due to high hospitalization rates, availability of advanced products, skilled healthcare providers, and favorable reimbursement frameworks. The home care segment is projected to register the highest CAGR going forward, reflecting a broader shift toward patient-centric care models and the growing preference among elderly patients for managing chronic conditions at home.

Regional Landscape

North America dominates globally, commanding a 34.77% market share in 2025, supported by high disease prevalence, robust R&D investment, advanced healthcare infrastructure, and strong reimbursement policies. The U.S. alone has approximately 10 million people living with lymphedema, according to the Lymphatic Education & Research Network.

Europe holds the second position, benefiting from the presence of major manufacturers, frequent product innovations, and widespread clinical adoption of compression garments.

Asia-Pacific is set to record the highest regional growth rate, driven by a rapidly aging population, rising disposable incomes, expanding healthcare infrastructure, and growing patient awareness. India is projected to grow at a CAGR of 7.00%, while Japan's market is expected to reach USD 246.0 million by 2025.

Latin America and the Middle East & Africa are expected to grow at moderate rates, supported by improving healthcare access and growing unmet medical needs.

Connect with Our Expert for any Queries: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/102689

Competitive Landscape

The market features a mix of established global players and innovative medical technology firms. Key companies include SIGVARIS, Essity Aktiebolag, Arjo, PAUL HARTMANN, medi GmbH & Co. KG, Smith & Nephew, Bio Compression Systems, and Tactile Systems Technology. These players are pursuing organic and inorganic growth strategies — including mergers, acquisitions, partnerships, and new product launches — to strengthen their market positions across regions.